NET-话题@MedSci

#NET#

967篇内容 | 2520人围观

关注话题

话题活跃用户

#插入话题

插入图片

最新最热

[GetTopicListResponse(id=1734235, encodeId=a8561e342355e, content=<a href='/topic/show?id=d4f412668a4' target=_blank style='color:#2F92EE;'>#NET#</a>, objectTitle=罗氏CD20xCD3双特异性抗体Mosunetuzumab治疗滤泡性淋巴瘤，获得FDA的突破性治疗指定, objectType=article, longId=197588, objectId=c63a19e588ba, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=c63a19e588ba, replyNumber=0, likeNumber=65, createdTime=2021-06-10, rootId=0, userName=canlab, userId=7ea033781210, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=c63a19e588ba, moduleTitle=罗氏CD20xCD3双特异性抗体Mosunetuzumab治疗滤泡性淋巴瘤，获得FDA的突破性治疗指定, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=c63a19e588ba)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1734202, encodeId=02fd1e3420215, content=<a href='/topic/show?id=d4f412668a4' target=_blank style='color:#2F92EE;'>#NET#</a>, objectTitle=Blood：决定AML老年患者经venetoclax联合化疗预后的分子特征！, objectType=article, longId=186298, objectId=345e18629866, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=345e18629866, replyNumber=0, likeNumber=64, createdTime=2020-08-16, rootId=0, userName=canlab, userId=7ea033781210, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=345e18629866, moduleTitle=Blood：决定AML老年患者经venetoclax联合化疗预后的分子特征！, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=345e18629866)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1734225, encodeId=559e1e342252d, content=<a href='/topic/show?id=d4f412668a4' target=_blank style='color:#2F92EE;'>#NET#</a>, objectTitle=杀死乳腺癌细胞！“网红抗癌药”Venetoclax再显奇效, objectType=article, longId=194517, objectId=df0c19451edd, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=df0c19451edd, replyNumber=0, likeNumber=69, createdTime=2021-04-04, rootId=0, userName=canlab, userId=7ea033781210, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=df0c19451edd, moduleTitle=杀死乳腺癌细胞！“网红抗癌药”Venetoclax再显奇效, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=df0c19451edd)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1734183, encodeId=7f221e3418308, content=<a href='/topic/show?id=d4f412668a4' target=_blank style='color:#2F92EE;'>#NET#</a>, objectTitle=PLoS Genet：吸烟会加快面部老化，你还敢吸烟吗？, objectType=article, longId=182566, objectId=df371825661f, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=df371825661f, replyNumber=0, likeNumber=76, createdTime=2020-09-21, rootId=0, userName=canlab, userId=7ea033781210, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=df371825661f, moduleTitle=PLoS Genet：吸烟会加快面部老化，你还敢吸烟吗？, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=df371825661f)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1734194, encodeId=156d1e3419422, content=<a href='/topic/show?id=d4f412668a4' target=_blank style='color:#2F92EE;'>#NET#</a>, objectTitle=J Clin Oncol：ganetespib联合多西他赛治疗晚期肺腺癌, objectType=article, longId=184803, objectId=12f4184803fa, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=12f4184803fa, replyNumber=0, likeNumber=61, createdTime=2020-11-23, rootId=0, userName=canlab, userId=7ea033781210, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=12f4184803fa, moduleTitle=J Clin Oncol：ganetespib联合多西他赛治疗晚期肺腺癌, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=12f4184803fa)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1734189, encodeId=c3431e34189d7, content=<a href='/topic/show?id=d4f412668a4' target=_blank style='color:#2F92EE;'>#NET#</a>, objectTitle=LM-030治疗Netherton综合征：已获欧洲委员会的孤儿药认定, objectType=article, longId=182983, objectId=826118298353, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=826118298353, replyNumber=0, likeNumber=56, createdTime=2020-03-29, rootId=0, userName=canlab, userId=7ea033781210, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=826118298353, moduleTitle=LM-030治疗Netherton综合征：已获欧洲委员会的孤儿药认定, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=826118298353)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1734242, encodeId=b1ee1e34242ea, content=<a href='/topic/show?id=d4f412668a4' target=_blank style='color:#2F92EE;'>#NET#</a>, objectTitle=Clin Cancer Res：Ganetespib联合培美曲塞+铂类治疗恶性胸膜间皮瘤, objectType=article, longId=198667, objectId=2f6b19866e72, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=2f6b19866e72, replyNumber=0, likeNumber=106, createdTime=2020-10-16, rootId=0, userName=canlab, userId=7ea033781210, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=2f6b19866e72, moduleTitle=Clin Cancer Res：Ganetespib联合培美曲塞+铂类治疗恶性胸膜间皮瘤, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=2f6b19866e72)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1734214, encodeId=4dd91e3421499, content=<a href='/topic/show?id=d4f412668a4' target=_blank style='color:#2F92EE;'>#NET#</a>, objectTitle=Blood：Venetoclax联合LDAC可改善不适合强化化疗的AML患者的临床预后, objectType=article, longId=191468, objectId=649219146815, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=649219146815, replyNumber=0, likeNumber=67, createdTime=2020-05-27, rootId=0, userName=canlab, userId=7ea033781210, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=649219146815, moduleTitle=Blood：Venetoclax联合LDAC可改善不适合强化化疗的AML患者的临床预后, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=649219146815)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1734228, encodeId=d0d71e342281c, content=<a href='/topic/show?id=d4f412668a4' target=_blank style='color:#2F92EE;'>#NET#</a>, objectTitle=ASCO 2020丨陈洁教授：纵使微小，也需努力前行，ASCO上NETs相关研究, objectType=article, longId=196206, objectId=552119620647, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=552119620647, replyNumber=0, likeNumber=57, createdTime=2021-04-08, rootId=0, userName=canlab, userId=7ea033781210, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=552119620647, moduleTitle=ASCO 2020丨陈洁教授：纵使微小，也需努力前行，ASCO上NETs相关研究, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=552119620647)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1734198, encodeId=7f271e34198a4, content=<a href='/topic/show?id=d4f412668a4' target=_blank style='color:#2F92EE;'>#NET#</a>, objectTitle=JAMA Network Open：DAYVIGO（lemborexant）治疗失眠症的关键III期研究, objectType=article, longId=185379, objectId=6b761853e9f9, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=6b761853e9f9, replyNumber=0, likeNumber=65, createdTime=2020-02-25, rootId=0, userName=canlab, userId=7ea033781210, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=6b761853e9f9, moduleTitle=JAMA Network Open：DAYVIGO（lemborexant）治疗失眠症的关键III期研究, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=6b761853e9f9)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1734209, encodeId=c29c1e3420968, content=<a href='/topic/show?id=d4f412668a4' target=_blank style='color:#2F92EE;'>#NET#</a>, objectTitle=Lancet：Nerinetide用于缺血性脑卒中患者神经保护, objectType=article, longId=188550, objectId=5df0188550cb, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=5df0188550cb, replyNumber=0, likeNumber=85, createdTime=2020-03-25, rootId=0, userName=canlab, userId=7ea033781210, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=5df0188550cb, moduleTitle=Lancet：Nerinetide用于缺血性脑卒中患者神经保护, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=5df0188550cb)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1734173, encodeId=32201e3417315, content=<a href='/topic/show?id=d4f412668a4' target=_blank style='color:#2F92EE;'>#NET#</a>, objectTitle=JAMA Netw Open：美国60年随访研究首次发现，儿童期接种卡介苗还能预防肺癌, objectType=article, longId=180128, objectId=a6c31801285c, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=a6c31801285c, replyNumber=0, likeNumber=61, createdTime=2019-11-05, rootId=0, userName=canlab, userId=7ea033781210, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=a6c31801285c, moduleTitle=JAMA Netw Open：美国60年随访研究首次发现，儿童期接种卡介苗还能预防肺癌, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=a6c31801285c)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1734174, encodeId=78c51e341743c, content=<a href='/topic/show?id=d4f412668a4' target=_blank style='color:#2F92EE;'>#NET#</a>, objectTitle=Front Genet：汉族人群中各种类型角膜营养不良相关的新型突变, objectType=article, longId=180208, objectId=bd2918020896, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=bd2918020896, replyNumber=0, likeNumber=107, createdTime=2020-07-28, rootId=0, userName=canlab, userId=7ea033781210, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=bd2918020896, moduleTitle=Front Genet：汉族人群中各种类型角膜营养不良相关的新型突变, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=bd2918020896)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1734181, encodeId=80a31e341812c, content=<a href='/topic/show?id=d4f412668a4' target=_blank style='color:#2F92EE;'>#NET#</a>, objectTitle=Nat Genet：无义介导的mRNA降解在遗传病、基因编辑以及肿瘤免疫治疗中的研究, objectType=article, longId=182326, objectId=1e771823263a, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=1e771823263a, replyNumber=0, likeNumber=69, createdTime=2020-07-29, rootId=0, userName=canlab, userId=7ea033781210, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=1e771823263a, moduleTitle=Nat Genet：无义介导的mRNA降解在遗传病、基因编辑以及肿瘤免疫治疗中的研究, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=1e771823263a)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1734180, encodeId=302b1e3418015, content=<a href='/topic/show?id=d4f412668a4' target=_blank style='color:#2F92EE;'>#NET#</a>, objectTitle=Seattle Genetics的酪氨酸激酶抑制剂tucatinib治疗晚期或转移性乳腺癌临床试验成功, objectType=article, longId=181705, objectId=c214181e05e3, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=c214181e05e3, replyNumber=0, likeNumber=56, createdTime=2020-05-17, rootId=0, userName=canlab, userId=7ea033781210, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=c214181e05e3, moduleTitle=Seattle Genetics的酪氨酸激酶抑制剂tucatinib治疗晚期或转移性乳腺癌临床试验成功, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=c214181e05e3)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1734171, encodeId=49b51e341715c, content=<a href='/topic/show?id=d4f412668a4' target=_blank style='color:#2F92EE;'>#NET#</a>, objectTitle=Clinica Chimica Acta：血清netrin-1可作为动脉瘤性蛛网膜下腔出血的预后生物标志物, objectType=article, longId=179867, objectId=ea9c1e986727, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=ea9c1e986727, replyNumber=0, likeNumber=60, createdTime=2020-02-27, rootId=0, userName=canlab, userId=7ea033781210, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=ea9c1e986727, moduleTitle=Clinica Chimica Acta：血清netrin-1可作为动脉瘤性蛛网膜下腔出血的预后生物标志物, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=ea9c1e986727)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1734201, encodeId=4c341e34201e1, content=<a href='/topic/show?id=d4f412668a4' target=_blank style='color:#2F92EE;'>#NET#</a>, objectTitle=JAMA Netw Open:中国仅14.8%心衰患者出院时处方β受体阻滞剂！首次中国心衰医疗质量评估：出院时预约随访比例仅11.8%, objectType=article, longId=186120, objectId=462318612022, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=462318612022, replyNumber=0, likeNumber=103, createdTime=2020-11-25, rootId=0, userName=canlab, userId=7ea033781210, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=462318612022, moduleTitle=JAMA Netw Open:中国仅14.8%心衰患者出院时处方β受体阻滞剂！首次中国心衰医疗质量评估：出院时预约随访比例仅11.8%, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=462318612022)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1734208, encodeId=6dd01e3420854, content=<a href='/topic/show?id=d4f412668a4' target=_blank style='color:#2F92EE;'>#NET#</a>, objectTitle=Nat Genet：人类癌症中病毒分布, objectType=article, longId=188381, objectId=c033188381e3, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=c033188381e3, replyNumber=0, likeNumber=94, createdTime=2020-05-04, rootId=0, userName=canlab, userId=7ea033781210, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=c033188381e3, moduleTitle=Nat Genet：人类癌症中病毒分布, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=c033188381e3)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1734176, encodeId=4b021e341760d, content=<a href='/topic/show?id=d4f412668a4' target=_blank style='color:#2F92EE;'>#NET#</a>, objectTitle=Am J Hum Genet：发现PTEN突变人群潜在标志物：可区分癌症和自闭症, objectType=article, longId=180375, objectId=75891803e50f, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=75891803e50f, replyNumber=0, likeNumber=63, createdTime=2019-11-25, rootId=0, userName=canlab, userId=7ea033781210, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=75891803e50f, moduleTitle=Am J Hum Genet：发现PTEN突变人群潜在标志物：可区分癌症和自闭症, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=75891803e50f)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1734191, encodeId=7b371e3419188, content=<a href='/topic/show?id=d4f412668a4' target=_blank style='color:#2F92EE;'>#NET#</a>, objectTitle=Nat Genet：化疗引发基因突变？癌症治疗毒副作用关键机制首次揭秘！, objectType=article, longId=183404, objectId=84b11834048b, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=84b11834048b, replyNumber=0, likeNumber=61, createdTime=2020-11-07, rootId=0, userName=canlab, userId=7ea033781210, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=84b11834048b, moduleTitle=Nat Genet：化疗引发基因突变？癌症治疗毒副作用关键机制首次揭秘！, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=84b11834048b)], followStatus=false, userIsMember=false, type=1, lengthMark=0)] 梅斯话题小助手

NET

2020-05-29

canlab (审核中...)

前往app查看评论内容

#NET#

罗氏CD20xCD3双特异性抗体Mosunetuzumab治疗滤泡性淋巴瘤，获得FDA的突破性治疗指定

2021-06-10

canlab (审核中...)

前往app查看评论内容

#NET#

Blood：决定AML老年患者经venetoclax联合化疗预后的分子特征！

2020-08-16

canlab (审核中...)

前往app查看评论内容

#NET#

杀死乳腺癌细胞！“网红抗癌药”Venetoclax再显奇效

2021-04-04

canlab (审核中...)

前往app查看评论内容

#NET#

PLoS Genet：吸烟会加快面部老化，你还敢吸烟吗？

2020-09-21

canlab (审核中...)

前往app查看评论内容

#NET#

J Clin Oncol：ganetespib联合多西他赛治疗晚期肺腺癌

2020-11-23

canlab (审核中...)

前往app查看评论内容

#NET#

LM-030治疗Netherton综合征：已获欧洲委员会的孤儿药认定

2020-03-29

canlab (审核中...)

前往app查看评论内容

#NET#

Clin Cancer Res：Ganetespib联合培美曲塞+铂类治疗恶性胸膜间皮瘤

2020-10-16

canlab (审核中...)

前往app查看评论内容

#NET#

Blood：Venetoclax联合LDAC可改善不适合强化化疗的AML患者的临床预后

2020-05-27

canlab (审核中...)

前往app查看评论内容

#NET#

ASCO 2020丨陈洁教授：纵使微小，也需努力前行，ASCO上NETs相关研究

2021-04-08

canlab (审核中...)

前往app查看评论内容

#NET#

JAMA Network Open：DAYVIGO（lemborexant）治疗失眠症的关键III期研究

2020-02-25

canlab (审核中...)

前往app查看评论内容

#NET#

Lancet：Nerinetide用于缺血性脑卒中患者神经保护

2020-03-25

canlab (审核中...)

前往app查看评论内容

#NET#

JAMA Netw Open：美国60年随访研究首次发现，儿童期接种卡介苗还能预防肺癌

2019-11-05

canlab (审核中...)

前往app查看评论内容

#NET#

Front Genet：汉族人群中各种类型角膜营养不良相关的新型突变

2020-07-28

canlab (审核中...)

前往app查看评论内容

#NET#

Nat Genet：无义介导的mRNA降解在遗传病、基因编辑以及肿瘤免疫治疗中的研究

2020-07-29

canlab (审核中...)

前往app查看评论内容

#NET#

Seattle Genetics的酪氨酸激酶抑制剂tucatinib治疗晚期或转移性乳腺癌临床试验成功

2020-05-17

canlab (审核中...)

前往app查看评论内容

#NET#

Clinica Chimica Acta：血清netrin-1可作为动脉瘤性蛛网膜下腔出血的预后生物标志物

2020-02-27

canlab (审核中...)

前往app查看评论内容

#NET#

JAMA Netw Open:中国仅14.8%心衰患者出院时处方β受体阻滞剂！首次中国心衰医疗质量评估：出院时预约随访比例仅11.8%

2020-11-25

canlab (审核中...)

前往app查看评论内容

#NET#

Nat Genet：人类癌症中病毒分布

2020-05-04

canlab (审核中...)

前往app查看评论内容

#NET#

Am J Hum Genet：发现PTEN突变人群潜在标志物：可区分癌症和自闭症

2019-11-25

canlab (审核中...)

前往app查看评论内容

#NET#

Nat Genet：化疗引发基因突变？癌症治疗毒副作用关键机制首次揭秘！

2020-11-07

科室
- - 订阅+
  - 更多科室
工具
服务